Baseline albumin-bilirubin (ALBI) in Western patients with hepatocellular carcinoma treated with stereotactic body radiotherapy (SBRT)

Murray, LJ orcid.org/0000-0003-0658-6455, Sykes, J, Brierley, J et al. (8 more authors) (2018) Baseline albumin-bilirubin (ALBI) in Western patients with hepatocellular carcinoma treated with stereotactic body radiotherapy (SBRT). International Journal of Radiation Oncology*Biology*Physics, 101 (4). pp. 900-909. ISSN 0360-3016

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier Inc. This is an author produced version of a paper published in International Journal of Radiation Oncology*Biology*Physics. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Hepatocellular carcinoma; SBRT; Albumin-bilirubin
Dates:
  • Accepted: 4 April 2018
  • Published (online): 12 April 2018
  • Published: 15 July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Depositing User: Symplectic Publications
Date Deposited: 08 Jun 2018 11:16
Last Modified: 12 Apr 2019 00:41
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ijrobp.2018.04.011

Download

Export

Statistics